Humana Inc. (NYSE: HUM) Investor Alert: Securities Fraud Case Moves Forward Following 22% Stock Drop; Schubert Jonckheer Investigating
Humana Inc. (NYSE: HUM) Investor Alert: Securities Fraud Case Moves Forward Following 22% Stock Drop; Schubert Jonckheer Investigating |
| [06-October-2026] |
SAN FRANCISCO, Oct. 6, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential wrongdoing at Humana Inc. (NYSE: HUM) following a court ruling that key claims in a securities fraud lawsuit against Humana and its former CEO and CFO will move forward. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.com/humana. The lawsuit alleges Humana misled investors between July 2022 and October 2024 regarding its exposure to rising costs as patients returned for medical care after the pandemic, causing its stock to trade at artificially inflated prices. U.S. District Judge Jennifer L. Hall found the complaint sufficiently alleged that defendants acted with an intent to defraud in making false and misleading statements. During this period, insiders sold over $104 million in stock. When the truth was fully revealed in October 2024 and Humana reported sharp declines in many of its plans' Star ratings, the stock price fell 22%. We are investigating potential wrongdoing by Humana's directors and officers in connection with these allegations. If you own Humana stock, you may have legal options. Visit https://www.classactionlawyers.com/humanato learn more. About Schubert Jonckheer & Kolbe LLP Contact
SOURCE Schubert Jonckheer & Kolbe LLP | ||
Company Codes: NYSE:HUM |
View original content:
